Colonics
About Me
Recent Posts
- 4 Mushroom Poisonings In 2 Weeks - Doctors Test Milk Thistle As Treatment
- Improved Diagnostics For Sleeping Sickness
- Prostate Growth May Be Slowed By Statins
- New Tools For Psychological Science Research - Facebook And Smartphones
- Finding That Oxytocin Improves Brain Function In Children With Autism Could Lead To Treatment For Associated Social Deficits
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
Friends
Links
Entry 1 of 2380
Last Page | Next Page
12/19/2009
-
Amgen Receives CHMP Positive Opinion For Prolia(TM) (Denosumab) In The European Union
|
Amgen Inc. (Nasdaq: AMGN) announced that the panel for Medicinal vendibles for Human Use (CHMP) of the latin Medicines Agency (EMA) has announced a concrete opinion for the marketing sanction
More: - Read the rest here |
Post A Comment! :: Send to a Friend! |
for the rehabilitation of osteoporosis in postmenopausal women at increased risk of fractures, and for the therapy of bone loss customer's broker with hormone ablation in men with prostate cancer at increased risk of fractures. If approved by the latin Commission, Amgen would receive selling license for Prolia in all spanish Union (EU) Member States...Share and enjoy
